HighTower Advisors, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$1,566,000
+1.2%
10,361
-2.5%
0.00%0.0%
Q2 2022$1,548,000
+14.7%
10,630
-6.4%
0.00%
+33.3%
Q1 2022$1,350,000
-28.1%
11,357
-16.1%
0.00%
-25.0%
Q4 2021$1,877,000
+351.2%
13,531
+352.4%
0.00%
+300.0%
Q3 2021$416,000
-16.8%
2,991
-56.2%
0.00%
-66.7%
Q2 2020$500,0006,8250.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders